ArticleBMC cancer2023

Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy.

Hanzhi Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.